• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Alex Veiga

    Alex Veiga

    Valeant sweetens offer for Allergan again
    Business

    Valeant sweetens offer for Allergan again

    Alex Veiga -
    May 30, 2014 10:57 pm
    0
    In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory  in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File)
    Business

    Pfizer pulls plug on push to buy AstraZeneca

    Alex Veiga -
    May 26, 2014 6:29 pm
    0
    FILE - This May 11, 2007 file photo shows a Wall Street sign in front of the flag-draped facade of the New York Stock Exchange. U.S. stocks edged higher in early trading Thursday, May 22, 2014, extending gains from a day earlier. Investors cheered earnings news from several retailers, including Best Buy, Dollar Tree and L Brands. Sears fell sharply after reporting disappointing results. (AP Photo/Richard Drew, File)
    Business

    Economic data on US, China boost stocks

    Alex Veiga -
    May 22, 2014 9:38 pm
    0
    FILE - This file photo made April 22, 2010 shows a Wall Street sign in front of the New York Stock Exchange. U.S. stock futures rose on Wednesday, May 21, 2014, as investors await the minutes from the Federal Reserve's most recent meeting in April. (AP Photo/Mark Lennihan, File)
    Business

    US stocks recover; Tiffany shines on earnings gain

    Alex Veiga -
    May 21, 2014 9:09 pm
    0
    Traders gather at the post that handles AT&T on the floor of the New York Stock Exchange Monday, May 19, 2014. Priming itself for the age of Internet-delivered video, AT&T Inc. said it would buy DirecTV for $48.5 billion in cash and stock, or $95 per share. (AP Photo/Richard Drew)
    Business

    Stocks edge higher after drifting in early trade

    Alex Veiga -
    May 19, 2014 8:54 pm
    0
    5 tips for new parents considering life insurance
    Business

    5 tips for new parents considering life insurance

    Alex Veiga -
    May 16, 2014 8:17 pm
    0
    In this Friday, March 21, 2014 photo, Pete Christman installs a remote control for a fan in a new home in Pepper Pike, Ohio. The National Association of Home Builders reports on sentiment among U.S. builders on Thursday, May 15, 2014. (AP Photo/Tony Dejak)
    Business

    US homebuilder confidence slips in May

    Alex Veiga -
    May 15, 2014 3:00 pm
    0
    Your choice: fixed or adjustable-rate mortgage?
    Business

    Your choice: fixed or adjustable-rate mortgage?

    Alex Veiga -
    April 25, 2014 5:24 pm
    0
    FILE - In this April 25, 2013 file photo, credit and debit cards are displayed for a photographer in Baltimore. Visa Inc. reports quarterly earnings on Thursday, April 24, 2014. (AP Photo/Patrick Semansky, File)
    Business

    Visa’s 2Q profit jumps 26 percent as payments grow

    Alex Veiga -
    April 24, 2014 11:12 pm
    0
    FILE - In this Friday, April 11, 2014 photo, trader Anthony Carannante, left, works on the floor of the New York Stock Exchange. A government report showing March retail sales notched their biggest increase in 18 months helped give U.S. stocks a lift Monday, April 14, 2014. Better-than-expected results from Citigroup helped ease worries that first-quarter corporate earnings would be weak. (AP Photo/Richard Drew, File)
    Business

    US stock market ends higher as earnings pour in

    Alex Veiga -
    April 17, 2014 9:56 pm
    0
    1...345...12Page 4 of 12
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter